MTNB - Matinas BioPharma Holdings, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.87 0.03 (1.6%) --- --- --- --- 0.03 (1.6%) 0.0 (0.0%) 0.0 (0.0%)

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.03
Diluted EPS:
-1.03
Basic P/E:
-1.8447
Diluted P/E:
-1.8447
RSI(14) 1m:
100.0
VWAP:
1.9
RVol:
0.9785

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.85 -0.03 (-1.6%) Oct 15 14:50
1m Price increase 1m 1.85 +0.03 (+1.65%) Oct 15 14:20
1m Price decrease 1m 1.8 -0.04 (-2.17%) Oct 15 13:10
1m Price decrease 1m 1.8 -0.05 (-2.7%) Oct 15 13:09
10m Price decrease 10m 1.8 -0.07 (-3.74%) Oct 15 13:09

Related News